![Christer Nordstedt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christer Nordstedt
Direttore/Membro del Consiglio presso
IRLAB THERAPEUTICS AB
Profilo
Christer Nordstedt currently works at Oblique Therapeutics AB, as Chief Executive Officer from 2022, Snevringe AB, as Chairman, IRLAB Therapeutics AB, as Director from 2023, and CINDA PHARMA AB, as Director.
Dr. Nordstedt also formerly worked at Vivesto AB, as Chief Executive Officer in 2022, Wntresearch AB, as Chairman, Orion Diagnostica AB, as Director from 2017 to 2019, Fermion Ltd., as Director from 2017 to 2020, Orion Oyj, as Senior Vice President-Research & Development from 2017 to 2020, Teva GmbH, as Global Research Manager, AstraZeneca AB, as Vice President from 2000 to 2007, Hoffman-LaRoche F & Co. AG, as Senior Vice President, and Eli Lilly Sweden AB, as Senior Vice President from 2011 to 2017.
Dr. Nordstedt received his doctorate degree in 1991 from Karolinska Institutet.
Posizioni attive di Christer Nordstedt
| Società | Posizione | Inizio |
|---|---|---|
| IRLAB THERAPEUTICS AB | Direttore/Membro del Consiglio | 01/01/2023 |
Snevringe AB | Presidente | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Amministratore Delegato | 01/12/2022 |
CINDA PHARMA AB
 CINDA PHARMA AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christer Nordstedt
| Società | Posizione | Fine |
|---|---|---|
| VIVESTO AB | Amministratore Delegato | 30/11/2022 |
| ORION OYJ | Direttore Tecnico/Scientifico/R&S | 05/03/2020 |
Fermion Ltd. | Direttore/Membro del Consiglio | 01/01/2020 |
Orion Diagnostica AB | Direttore/Membro del Consiglio | 01/01/2019 |
Eli Lilly Sweden AB
 Eli Lilly Sweden AB Eli Lilly Sweden AB is a pharmaceutical company that develops and delivers medicines for conditions including obesity, diabetes, cancer, immunology, pain, neurological disorders, osteoporosis, cardiovascular diseases, and endocrinology. The company is based in Solna, Sweden. The Swedish company also provides educational resources for healthcare professionals, such as live online lectures on obesity and type 2 diabetes, and offers information on medicines, patient safety, and company news through its website. The company was founded by Colonel Eli Lilly. | Corporate Officer/Principal | 01/02/2017 |
Formazione di Christer Nordstedt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
40
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Orion Oyj
 Orion Oyj Pharmaceuticals: MajorHealth Technology Manufactures and markets human and veterinary pharmaceuticals | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Vivesto AB
 Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Teva GmbH
 Teva GmbH Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Eli Lilly Sweden AB
Eli Lilly Sweden AB Eli Lilly Sweden AB is a pharmaceutical company that develops and delivers medicines for conditions including obesity, diabetes, cancer, immunology, pain, neurological disorders, osteoporosis, cardiovascular diseases, and endocrinology. The company is based in Solna, Sweden. The Swedish company also provides educational resources for healthcare professionals, such as live online lectures on obesity and type 2 diabetes, and offers information on medicines, patient safety, and company news through its website. The company was founded by Colonel Eli Lilly. | |
Orion Diagnostica AB | |
Fermion Ltd. | |
IRLAB Therapeutics AB
 IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
Snevringe AB | |
CINDA PHARMA AB
CINDA PHARMA AB Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
